Trial Profile
Bioavailability study of extended-release methylphenidate (MPH-MLR) capsule vs immediate-release methylphenidate tablets in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Pharmacokinetics
- 02 Dec 2015 New trial record